The journal Prostate recently published a study showing that prostate cancer incidence among distant relatives on both sides of a man’s family can help predict whether he will develop the disease.
The study revealed that family history was just as effective at predicting disease incidence as the prostate-specific antigen (PSA) test, a common screening test for prostate cancer. While the screening test increased the number of diagnoses, the proportion of cases associated with family history remained the same before and after the advent of the PSA test. Authors of the study noted, “history of the disease among a man’s maternal relatives is just as big of a predictor as the incidence among his paternal relatives.”
Read more about the study and the findings here.
If you or a loved one is diagnosed with prostate cancer, contact Reno CyberKnife for a prostate cancer treatment consultation visit or to get a second opinion and learn more about CyberKnife® as a noninvasive treatment option.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.